IMMUCELL CORP /DE/
ICCC · XNASCIK 811641fmd_0R77KSN7XC4PM5DFQBR1H806A6Manufacturing · In Vitro & In Vivo Diagnostic SubstancesTemplate: Standard
Coverage: Jan 01, 2009 to Sep 30, 2026, 67 periods
0 filings
From 8-K filings, not wire news: the items each filer selected on the EDGAR cover, grouped by event type. Importance is FinancialMD's own rule by item number (5: bankruptcy, non-reliance, change of control, delisting, cybersecurity; 1: exhibits only).
Loading